Lisa M Guay-Woodford Selected Research

Therapeutics

1/2019	CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular Disease.
9/2014	Autosomal recessive polycystic kidney disease: a hepatorenal fibrocystic disorder with pleiotropic effects.
1/2014	Autosomal recessive polycystic kidney disease: the prototype of the hepato-renal fibrocystic diseases.
7/2007	Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease.
12/2003	Magnetic resonance measurements of renal blood flow as a marker of disease severity in autosomal-dominant polycystic kidney disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lisa M Guay-Woodford Research Topics

Disease

19	Autosomal Recessive Polycystic Kidney (Polycystic Kidney Disease, Infantile, Type I) 01/2023 - 04/2000
12	Autosomal Dominant Polycystic Kidney (ADPKD) 12/2023 - 04/2002
8	Polycystic Kidney Diseases (Polycystic Kidney Disease) 01/2023 - 02/2002
8	Cysts 01/2007 - 04/2000
5	Hypertension (High Blood Pressure) 10/2017 - 02/2003
4	Disease Progression 12/2023 - 04/2006
1	Body Weight (Weight, Body) 01/2023
1	Liver Diseases (Liver Disease) 01/2023
1	Chemical and Drug Induced Liver Injury 01/2023
1	Hypernatremia 01/2023
1	Neoplasms (Cancer) 01/2021
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2019
1	IGA Glomerulonephritis (IGA Nephropathy) 01/2019
1	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 01/2019
1	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 01/2019
1	Membranous Glomerulonephritis (Membranous Nephropathy) 01/2019
1	Fibrosis (Cirrhosis) 10/2017
1	Proteinuria 06/2015
1	Kidney Diseases (Kidney Disease) 06/2015
1	Colonic Neoplasms (Colon Cancer) 10/2010
1	Ciliopathies 10/2010
1	Nephrotic Syndrome (Syndrome, Nephrotic) 07/2010
1	diffuse Mesangial sclerosis 07/2010
1	Azotemia 05/2006
1	Renal Insufficiency (Renal Failure) 12/2003

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 01/2023 - 02/2002
4	Iothalamic Acid (Iotalamic Acid)FDA Link 01/2007 - 09/2003
3	Tolvaptan FDA Link 12/2023 - 01/2023
3	Biomarkers (Surrogate Marker)IBA 01/2019 - 12/2003
3	CreatinineIBA 03/2006 - 09/2003
2	Transcription Factors (Transcription Factor)IBA 01/2022 - 05/2002
2	SodiumIBA 10/2017 - 01/2007
2	Antihypertensive Agents (Antihypertensives)IBA 10/2014 - 02/2003
2	AlbuminsIBA 01/2007 - 09/2003
1	Messenger RNA (mRNA)IBA 01/2023
1	ProteomeIBA 01/2023
1	Transaminases (Aminotransferases)IBA 01/2023
1	necdinIBA 01/2021
1	Immunoglobulin A (IgA)IBA 01/2019
1	Sirolimus (Rapamycin)FDA Link 12/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2018
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 10/2017
1	Biocompatible Materials (Biomaterials)IBA 01/2017
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 06/2015
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 06/2015
1	Dexamethasone (Maxidex)FDA LinkGeneric 06/2015
1	Apolipoprotein L1IBA 06/2015
1	3- (3,5- dichlorophenyl)- 1- methyl- 2,5- pyrrolidinedione (DPMS)IBA 06/2011
1	Hepatocyte Nuclear Factor 6IBA 06/2011
1	AntigensIBA 10/2010
1	Retinaldehyde (Retinal)IBA 10/2010
1	phospholipase C epsilonIBA 07/2010
1	AcidsIBA 12/2009
1	GadoliniumIBA 04/2009
1	Uric Acid (Urate)IBA 01/2007
1	LDL CholesterolIBA 01/2007
1	CalciumIBA 06/2006
1	A-factor (Streptomyces)IBA 06/2006
1	KinesinsIBA 04/2005
1	ElectrolytesIBA 09/2003
1	plexinIBA 05/2002
1	Immunoglobulins (Immunoglobulin)IBA 05/2002
1	Adenosine Triphosphate (ATP)IBA 04/2002
1	LectinsIBA 04/2000

Therapy/Procedure

5	Therapeutics 01/2019 - 12/2003
1	Euthanasia (Mercy Killing) 08/2015